Alzheimer’s is a global health problem, with nearly 7 million people living with the disease in the United States alone. Tremendous gains have been made in the understanding of the science and basic biology underlying Alzheimer’s and other dementias. These advances are leading to great strides in strategies for prevention, detection, diagnostics and therapeutic interventions. 

The Alzheimer’s Association is a global leader in research, mobilizing the field to advance the vision of a world without Alzheimer’s and all other dementia. This presentation will include: Highlights in Early Detection and Diagnosis, Latest Advances in Clinical Trials, Treatments and Lifestyle Interventions, Risk Reduction, and Alzheimer’s Association initiatives and how you can get involved.

About the Speaker

Claire Day has been on the staff of the Alzheimer’s Association since 2001. She is the chief program officer at the Northern California and Northern Nevada Chapter and as such oversees all care and support operations and research initiatives. Day is a clinical social worker and in 2018 was appointed the Chapter Lead for the U.S. Study to Protect Brain Health Through Lifestyle Interventions to Reduce Risk in partnership with UC Davis. This is a two-year clinical trial to evaluate whether lifestyle interventions that simultaneously target multiple risk factors protect cognitive function in older adults at increased risk for cognitive decline.